meddevicedb.com FDA Device Reference

STEROID 21-HYDROXYLASE ANTIBODY (21-OHAB) RIA ASSAY KIT

K121046 Class II Traditional
Decision Date
2012-12-20
Sponsor / Applicant
Kronus Market Development Associates, Inc.

Technical Specification

510(k) Submission ID K121046
Product Code PCG
Medical Specialty / Panel Immunology
Regulation Citation 21 CFR 866.5660
Decision Date 2012-12-20
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

STEROID 21-HYDROXYLASE ANTIBODY (21-OHAB) RIA ASSAY KIT received FDA 510(k) clearance under submission number K121046, sponsored by Kronus Market Development Associates, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2012-12-20.

Classification & Regulation

This clearance is catalogued under FDA product code PCG and 21 CFR 866.5660, within the Immunology review panel as a Class II device.